Cantargia Presents Promising Preclinical Results on a Novel IL1RAP-Targeting Antibody-Drug ...
Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced an upcoming presentation of preclinical data on the development ...